These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 21688292)

  • 1. Chronic stress and antidepressant agomelatine induce region-specific changes in synapsin I expression in the rat brain.
    Dagyte G; Luiten PG; De Jager T; Gabriel C; Mocaër E; Den Boer JA; Van der Zee EA
    J Neurosci Res; 2011 Oct; 89(10):1646-57. PubMed ID: 21688292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The novel antidepressant agomelatine normalizes hippocampal neuronal activity and promotes neurogenesis in chronically stressed rats.
    Dagyte G; Trentani A; Postema F; Luiten PG; Den Boer JA; Gabriel C; Mocaër E; Meerlo P; Van der Zee EA
    CNS Neurosci Ther; 2010 Aug; 16(4):195-207. PubMed ID: 20236141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Agomelatine reverses the decrease in hippocampal cell survival induced by chronic mild stress.
    Dagytė G; Crescente I; Postema F; Seguin L; Gabriel C; Mocaër E; Boer JA; Koolhaas JM
    Behav Brain Res; 2011 Mar; 218(1):121-8. PubMed ID: 21115070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of agomelatine on memory deficits and hippocampal gene expression induced by chronic social defeat stress in mice.
    Martin V; Allaïli N; Euvrard M; Marday T; Riffaud A; Franc B; Mocaër E; Gabriel C; Fossati P; Lehericy S; Lanfumey L
    Sci Rep; 2017 Apr; 8():45907. PubMed ID: 28374847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Agomelatine (S20098) modulates the expression of cytoskeletal microtubular proteins, synaptic markers and BDNF in the rat hippocampus, amygdala and PFC.
    Ladurelle N; Gabriel C; Viggiano A; Mocaër E; Baulieu EE; Bianchi M
    Psychopharmacology (Berl); 2012 Jun; 221(3):493-509. PubMed ID: 22160164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The antidepressant agomelatine blocks the adverse effects of stress on memory and enables spatial learning to rapidly increase neural cell adhesion molecule (NCAM) expression in the hippocampus of rats.
    Conboy L; Tanrikut C; Zoladz PR; Campbell AM; Park CR; Gabriel C; Mocaer E; Sandi C; Diamond DM
    Int J Neuropsychopharmacol; 2009 Apr; 12(3):329-41. PubMed ID: 18706130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Agomelatine in the tree shrew model of depression: effects on stress-induced nocturnal hyperthermia and hormonal status.
    Schmelting B; Corbach-Söhle S; Kohlhause S; Schlumbohm C; Flügge G; Fuchs E
    Eur Neuropsychopharmacol; 2014 Mar; 24(3):437-47. PubMed ID: 23978391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hippocampal and behavioral dysfunctions in a mouse model of environmental stress: normalization by agomelatine.
    Boulle F; Massart R; Stragier E; Païzanis E; Zaidan L; Marday S; Gabriel C; Mocaer E; Mongeau R; Lanfumey L
    Transl Psychiatry; 2014 Nov; 4(11):e485. PubMed ID: 25423137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms contributing to the phase-dependent regulation of neurogenesis by the novel antidepressant, agomelatine, in the adult rat hippocampus.
    Soumier A; Banasr M; Lortet S; Masmejean F; Bernard N; Kerkerian-Le-Goff L; Gabriel C; Millan MJ; Mocaer E; Daszuta A
    Neuropsychopharmacology; 2009 Oct; 34(11):2390-403. PubMed ID: 19571795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repeated restraint stress-induced atrophy of glutamatergic pyramidal neurons and decreases in glutamatergic efflux in the rat amygdala are prevented by the antidepressant agomelatine.
    Grillo CA; Risher M; Macht VA; Bumgardner AL; Hang A; Gabriel C; Mocaër E; Piroli GG; Fadel JR; Reagan LP
    Neuroscience; 2015 Jan; 284():430-443. PubMed ID: 25280788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential and converging molecular mechanisms of antidepressants' action in the hippocampal dentate gyrus.
    Patrício P; Mateus-Pinheiro A; Irmler M; Alves ND; Machado-Santos AR; Morais M; Correia JS; Korostynski M; Piechota M; Stoffel R; Beckers J; Bessa JM; Almeida OF; Sousa N; Pinto L
    Neuropsychopharmacology; 2015 Jan; 40(2):338-49. PubMed ID: 25035085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of neuroplastic molecules in selected brain regions after chronic administration of the novel antidepressant agomelatine.
    Calabrese F; Molteni R; Gabriel C; Mocaer E; Racagni G; Riva MA
    Psychopharmacology (Berl); 2011 May; 215(2):267-75. PubMed ID: 21181122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beneficial behavioural and neurogenic effects of agomelatine in a model of depression/anxiety.
    Rainer Q; Xia L; Guilloux JP; Gabriel C; Mocaër E; Hen R; Enhamre E; Gardier AM; David DJ
    Int J Neuropsychopharmacol; 2012 Apr; 15(3):321-35. PubMed ID: 21473810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behavioural and neuroplastic effects of the new-generation antidepressant agomelatine compared to fluoxetine in glucocorticoid receptor-impaired mice.
    Païzanis E; Renoir T; Lelievre V; Saurini F; Melfort M; Gabriel C; Barden N; Mocaër E; Hamon M; Lanfumey L
    Int J Neuropsychopharmacol; 2010 Jul; 13(6):759-74. PubMed ID: 19775499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Changes of Expression and Methylation of Genes Involved in Oxidative Stress in Course of Chronic Mild Stress and Antidepressant Therapy with Agomelatine.
    Wigner P; Synowiec E; Jóźwiak P; Czarny P; Bijak M; Barszczewska G; Białek K; Szemraj J; Gruca P; Papp M; Śliwiński T
    Genes (Basel); 2020 Jun; 11(6):. PubMed ID: 32545212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behavioral and neurochemical characterization of TrkB-dependent mechanisms of agomelatine in glucocorticoid receptor-impaired mice.
    Boulle F; Velthuis H; Koedam K; Steinbusch HW; van den Hove DLA; Kenis G; Gabriel C; Mocaer E; Franc B; Rognan D; Mongeau R; Lanfumey L
    Eur Neuropsychopharmacol; 2016 Jan; 26(1):65-77. PubMed ID: 26653128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of agomelatine in the chronic mild stress model of depression in the rat.
    Papp M; Gruca P; Boyer PA; Mocaër E
    Neuropsychopharmacology; 2003 Apr; 28(4):694-703. PubMed ID: 12655314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beyond the monoaminergic hypothesis: agomelatine, a new antidepressant with an innovative mechanism of action.
    Kasper S; Hamon M
    World J Biol Psychiatry; 2009; 10(2):117-26. PubMed ID: 19255935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Agomelatine-induced modulation of brain-derived neurotrophic factor (BDNF) in the rat hippocampus.
    Lu Y; Ho CS; McIntyre RS; Wang W; Ho RC
    Life Sci; 2018 Oct; 210():177-184. PubMed ID: 30193943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anxiolytic properties of agomelatine, an antidepressant with melatoninergic and serotonergic properties: role of 5-HT2C receptor blockade.
    Millan MJ; Brocco M; Gobert A; Dekeyne A
    Psychopharmacology (Berl); 2005 Feb; 177(4):448-58. PubMed ID: 15289999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.